BioVie Inc.
BIVI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $10 | $137 | $18 | $31 |
| - Cash | $25 | $18 | $23 | $24 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$15 | $119 | -$5 | $7 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$3 | -$3 | -$7 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$3 | -$3 | -$7 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.98 | -1.82 | -1.5 | -4.6 |
| % Growth | 46.2% | -21.3% | 67.4% | – |
| Operating Cash Flow | -$3 | -$6 | -$1 | -$9 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$6 | -$1 | -$9 |